Bottom line
POVSX vs FCENX: the short answer
POVSX (Putnam International Equity Fund /ma/) and FCENX (Franklin International Core Equity (IU) Fund) are both mutual funds.
FCENX is cheaper at 0% vs 1.21% — a difference of $121 a year per $10,000 invested.
Over five years, POVSX returned +8.0% a year vs +5.7% for FCENX (reporting dates differ).
POVSX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
POVSX vs FCENX side by side
| POVSX | FCENX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | Franklin Templeton |
| Category | International Stock | International Stock |
| Expense ratio | 1.21% | 0% |
| Annual cost per $10k | $121 | $0 |
| 10-yr cost on $10k (prospectus) | $1,967 | $60 |
| Max front load | 5.75% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +29.3% | +5.1% |
| 5-yr return (annualized) | +8.0% | +5.7% |
| 10-yr return (annualized) | +7.4% | — |
| Best quarter | +17.2% | +17.0% |
| Worst quarter | −20.7% | −19.6% |
| Net assets (fund) | $1.0B | $366.5M |
| Number of holdings | 251 | 218 |
| Portfolio turnover | 75% | 66% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | POVSX | FCENX | Difference |
|---|---|---|---|
| 2024 | +3.5% | +5.1% | −1.6% |
| 2023 | +18.6% | +20.7% | −2.1% |
| 2022 | −14.8% | −17.3% | +2.4% |
| 2021 | +8.7% | +15.0% | −6.3% |
| 2020 | +11.7% | +9.4% | +2.4% |
Source: Fund prospectus bar charts
Holdings overlap
12 of POVSX's top 25 holdings also appear in FCENX's top 25.
| Holding | POVSX | FCENX |
|---|---|---|
| ASML Holding NV | 3.92% | 2.76% |
| AstraZeneca plc | 3.41% | 1.40% |
| Mitsubishi UFJ Financial Group, Inc. | 3.03% | 2.09% |
| Roche Holding AG | 2.96% | 1.91% |
| Safran SA | 2.89% | 1.56% |
| Iberdrola SA | 2.76% | 1.24% |
| ABB Ltd. | 2.42% | 1.58% |
| BNP Paribas SA | 2.20% | 1.61% |
| Enel SpA | 2.07% | 1.34% |
| Sony Group Corp. | 1.95% | 1.62% |
| Novartis AG | 1.80% | 2.13% |
| AIA Group Ltd. | 1.75% | 1.28% |
Source: SEC Form N-PORT
POVSX top 10
- ASML Holding NV — 3.92%
- AstraZeneca plc — 3.41%
- Mitsubishi UFJ Financial Group, Inc. — 3.03%
- Roche Holding AG — 2.96%
- Safran SA — 2.89%
- British American Tobacco plc — 2.79%
- Sumitomo Mitsui Financial Group, Inc. — 2.79%
- Iberdrola SA — 2.76%
- Banco Santander SA — 2.76%
- BHP Group Ltd. — 2.50%
FCENX top 10
- ASML Holding NV — 2.76%
- HSBC Holdings plc — 2.66%
- Novartis AG — 2.13%
- Mitsubishi UFJ Financial Group, Inc. — 2.09%
- Roche Holding AG — 1.91%
- Sony Group Corp. — 1.62%
- BNP Paribas SA — 1.61%
- ABB Ltd. — 1.58%
- Safran SA — 1.56%
- ING Groep NV — 1.51%
FAQ
What is the difference between POVSX and FCENX?
Which is cheaper, POVSX or FCENX?
Should I own both POVSX and FCENX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.